TYROBP and Alzheimer disease: Finally, the Tyrobp/AD model work involves mice in which endogenous Tyrobp expression increases with disease stage, whereas it is not elevated at this age in the HD model, and so this is the first report showing that a decrease in microglial activity from homeostatic levels by Tyrobp deletion has definitive impact on a disease phenotype.